{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:44:33Z","timestamp":1791686673825,"version":"4.3.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12010-025-05516-6","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:29:56Z","timestamp":1767619796000},"page":"1696-1713","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["DDX11\/SKP2 Inhibits Cisplatin Sensitivity in Liver Cancer Cells by Regulating DNA Damage Repair and ER Stress"],"prefix":"10.1007","volume":"198","author":[{"given":"Shujia","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"12","key":"5516_CR1","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s12276-020-00527-1","volume":"52","author":"E Kim","year":"2020","unstructured":"Kim, E., & Viatour, P. (2020). Hepatocellular carcinoma: Old friends and new tricks [J]. Experimental & Molecular Medicine, 52(12), 1898\u20131907.","journal-title":"Experimental & Molecular Medicine"},{"key":"5516_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.omtn.2020.08.037","volume":"23","author":"Y Li","year":"2021","unstructured":"Li, Y., Zhang, Y., Zhang, S., et al. (2021). CircRNA circARNT2 suppressed the sensitivity of hepatocellular carcinoma cells to cisplatin by targeting the miR-155-5p\/PDK1 axis [J]. Mol Ther Nucleic Acids, 23, 244\u2013254.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"5516_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12951-023-01840-3","volume":"21","author":"Y Huang","year":"2023","unstructured":"Huang, Y., Kou, Q., Su, Y., et al. (2023). Combination therapy based on dual-target biomimetic nano-delivery system for overcoming cisplatin resistance in hepatocellular carcinoma [J]. Journal of Nanobiotechnology, 21(1), 89.","journal-title":"Journal of Nanobiotechnology"},{"issue":"1","key":"5516_CR4","doi-asserted-by":"publisher","first-page":"19319","DOI":"10.1038\/s41598-025-04008-1","volume":"15","author":"HM Sleem","year":"2025","unstructured":"Sleem, H. M., Ali, A. A., & Ramadan, E. (2025). Cisplatin Palbociclib combination differentially modulates PTEN AKT signaling via Hsp90 in hepatocellular carcinoma cells [J]. Scientific Reports, 15(1), 19319.","journal-title":"Scientific Reports"},{"issue":"2","key":"5516_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1871520620666200502004817","volume":"21","author":"MA Ragheb","year":"2021","unstructured":"Ragheb, M. A., Soliman, M. H., Elzayat, E. M., et al. (2021). MicroRNA-520c-3p modulates Doxorubicin-Chemosensitivity in HepG2 cells [J]. Anticancer Agents Med Chem, 21(2), 237\u2013245.","journal-title":"Anticancer Agents Med Chem"},{"key":"5516_CR6","doi-asserted-by":"publisher","first-page":"1419468","DOI":"10.3389\/fphar.2024.1419468","volume":"15","author":"W Mu","year":"2024","unstructured":"Mu, W., Zhi, Y., Zhou, J., et al. (2024). Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells [J]. Frontiers in Pharmacology, 15, 1419468.","journal-title":"Frontiers in Pharmacology"},{"issue":"5","key":"5516_CR7","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3892\/ol.2016.5181","volume":"12","author":"JR Kuo","year":"2016","unstructured":"Kuo, J. R., Shang, H. S., Ho, C. T., et al. (2016). Cisplatin-induced regulation of signal transduction pathways and transcription factors in p53-mutated subclone variants of hepatoma cells: Potential application for therapeutic targeting [J]. Oncology Letters, 12(5), 3723\u20133730.","journal-title":"Oncology Letters"},{"issue":"2","key":"5516_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2478\/raon-2019-0018","volume":"53","author":"T Makovec","year":"2019","unstructured":"Makovec, T. (2019). Cisplatin and beyond: Molecular mechanisms of action and drug resistance development in cancer chemotherapy [J]. Radiology and Oncology, 53(2), 148\u2013158.","journal-title":"Radiology and Oncology"},{"issue":"1","key":"5516_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymthe.2021.08.027","volume":"30","author":"P Li","year":"2022","unstructured":"Li, P., Song, R., Yin, F., et al. (2022). circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma [J]. Molecular Therapy: the Journal of the American Society of Gene Therapy, 30(1), 431\u2013447.","journal-title":"Molecular Therapy: the Journal of the American Society of Gene Therapy"},{"key":"5516_CR10","doi-asserted-by":"crossref","unstructured":"Pisani, F. M., Napolitano, E., Napolitano, L. M. R. (2018). Molecular and cellular functions of the Warsaw breakage syndrome DNA helicase DDX11 [J]. Genes (Basel), 9(11).","DOI":"10.3390\/genes9110564"},{"issue":"4","key":"5516_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41419-020-2478-0","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu, Y., Zhao, D., Li, K., et al. (2020). E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K\/AKT\/mTOR pathway [J]. Cell Death and Disease, 11(4), 273.","journal-title":"Cell Death and Disease"},{"key":"5516_CR12","doi-asserted-by":"publisher","first-page":"593293","DOI":"10.3389\/fonc.2020.593293","volume":"10","author":"SG Su","year":"2020","unstructured":"Su, S. G., Li, Q. L., Zhang, M. F., et al. (2020). An E2F1\/DDX11\/EZH2 positive feedback loop promotes cell proliferation in hepatocellular carcinoma [J]. Frontiers in Oncology, 10, 593293.","journal-title":"Frontiers in Oncology"},{"key":"5516_CR13","doi-asserted-by":"publisher","first-page":"641487","DOI":"10.3389\/fonc.2021.641487","volume":"11","author":"P Liu","year":"2021","unstructured":"Liu, P., Wei, J., Mao, F., et al. (2021). Establishment of a prognostic model for hepatocellular carcinoma based on Endoplasmic reticulum Stress-Related gene analysis [J]. Frontiers in Oncology, 11, 641487.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"5516_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12885-025-13433-4","volume":"25","author":"HY Wu","year":"2025","unstructured":"Wu, H. Y., Cao, S. Y., Xu, Z. G., et al. (2025). Construction of a radiogenomic signature based on Endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma [J]. BMC Cancer, 25(1), 131.","journal-title":"BMC Cancer"},{"key":"5516_CR15","doi-asserted-by":"crossref","unstructured":"Jegadesan, N. K., & BranzeI, D. (2021). DDX11 loss causes replication stress and Pharmacologically exploitable DNA repair defects [J]. Proceedings of the National Academy of Sciences of the United States of America, 118(17).","DOI":"10.1073\/pnas.2024258118"},{"issue":"1","key":"5516_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-022-02284-7","volume":"41","author":"IC Salaroglio","year":"2022","unstructured":"Salaroglio, I. C., Belisario, D. C., Bironzo, P., et al. (2022). SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma [J]. Journal of Experimental & Clinical Cancer Research: CR, 41(1), 75.","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"1","key":"5516_CR17","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-024-03157-x","volume":"43","author":"J Li","year":"2024","unstructured":"Li, J., Zhao, L., Wu, Z., et al. (2024). SelK promotes glioblastoma cell proliferation by inhibiting \u03b2-TrCP1 mediated ubiquitin-dependent degradation of CDK4 [J]. Journal of Experimental & Clinical Cancer Research: CR, 43(1), 231.","journal-title":"Journal of Experimental & Clinical Cancer Research: CR"},{"issue":"6","key":"5516_CR18","doi-asserted-by":"publisher","first-page":"e18137","DOI":"10.1111\/jcmm.18137","volume":"28","author":"S Zhang","year":"2024","unstructured":"Zhang, S., Ma, J., Yu, T., et al. (2024). circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR-338-5p\/IL-7 pathway [J]. Journal of Cellular and Molecular Medicine, 28(6), e18137.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"5516_CR19","doi-asserted-by":"crossref","unstructured":"Mahtab, M., Boavida, A., Santos, D. (2021). The genome stability maintenance DNA helicase DDX11 and its role in cancer [J]. Genes (Basel), 12(3).","DOI":"10.3390\/genes12030395"},{"issue":"14","key":"5516_CR20","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.yexcr.2013.06.005","volume":"319","author":"N Shah","year":"2013","unstructured":"Shah, N., Inoue, A., Woo Lee, S., et al. (2013). Roles of ChlR1 DNA helicase in replication recovery from DNA damage [J]. Experimental Cell Research, 319(14), 2244\u20132253.","journal-title":"Experimental Cell Research"},{"key":"5516_CR21","doi-asserted-by":"crossref","unstructured":"Gao, Y., Liu, J., Yao, X., et al. (2025). DDX11 interacts with PARP1 to facilitate PARylation, thereby promoting gallbladder cancer progression and conferring gemcitabine resistance [J]. Acta biochimica et biophysica Sinica.","DOI":"10.3724\/abbs.2025155"},{"key":"5516_CR22","doi-asserted-by":"crossref","unstructured":"He, D., Du, Z., Xu, H. (2022). Chl1, an ATP-Dependent DNA Helicase, inhibits DNA:RNA hybrids formation at DSB sites to maintain genome stability in S. pombe [J]. International Journal of Molecular Sciences, 23(12).","DOI":"10.3390\/ijms23126631"},{"key":"5516_CR23","doi-asserted-by":"crossref","unstructured":"Khaled, J., Kopsida, M., Lennern\u00e4s, H. (2022). Drug resistance and Endoplasmic reticulum stress in hepatocellular carcinoma [J]. Cells, 11(4).","DOI":"10.3390\/cells11040632"},{"issue":"1","key":"5516_CR24","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1186\/s12967-023-04351-9","volume":"21","author":"F Deng","year":"2023","unstructured":"Deng, F., Zhang, H., Zhou, W., et al. (2023). TRPA1 promotes cisplatin-induced acute kidney injury via regulating the Endoplasmic reticulum stress-mitochondrial damage [J]. Journal of Translational Medicine, 21(1), 695.","journal-title":"Journal of Translational Medicine"},{"issue":"1","key":"5516_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41420-022-00915-8","volume":"8","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q., Huang, Z., Rui, X., et al. (2022). GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2\u03b1 and activating the ER-stress response [J]. Cell Death Discovery, 8(1), 114.","journal-title":"Cell Death Discovery"},{"key":"5516_CR26","doi-asserted-by":"crossref","unstructured":"Wu, T., Gu, X., & Cui, H. (2021). Emerging roles of SKP2 in cancer drug resistance [J]. Cells, 10(5).","DOI":"10.3390\/cells10051147"},{"issue":"17","key":"5516_CR27","first-page":"9129","volume":"24","author":"Y Feng","year":"2020","unstructured":"Feng, Y., Li, B., Li, S. J., et al. (2020). Skp2\/p27 axis regulates chondrocyte proliferation under high glucose induced Endoplasmic reticulum stress [J]. European Review for Medical and Pharmacological Sciences, 24(17), 9129\u20139138.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"4","key":"5516_CR28","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/FBP.0000000000000773","volume":"35","author":"Q Liu","year":"2024","unstructured":"Liu, Q., Cheng, L., Li, F., et al. (2024). NSC689857, an inhibitor of Skp2, produces antidepressant-like effects in mice [J]. Behavioural Pharmacology, 35(4), 227\u2013238.","journal-title":"Behavioural Pharmacology"},{"issue":"13","key":"5516_CR29","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s41388-024-02942-4","volume":"43","author":"J Wang","year":"2024","unstructured":"Wang, J., Ferrena, A., Zhang, R., et al. (2024). Targeted Inhibition of SCF(SKP2) confers anti-tumor activities resulting in a survival benefit in osteosarcoma [J]. Oncogene, 43(13), 962\u2013975.","journal-title":"Oncogene"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-025-05516-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-025-05516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:04:44Z","timestamp":1773777884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-025-05516-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5516"],"URL":"https:\/\/doi.org\/10.1007\/s12010-025-05516-6","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors confirm that informed consent was obtained from all the subjects. All the methods\/studies were conducted in accordance with the Declaration of Helsinki. All animal experimental protocols were approved by the Animal Ethics Review Committee of Kunming Medical University (kmmu20240079), and the animal procedures adhered to the ARRIVE guidelines 2.0.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}